Collagen Type II-Targeting Lentiviral Gene Therapy for Mucopolysaccharidosis IVA. [PDF]
Celik B +4 more
europepmc +1 more source
Recent advances in mucopolysaccharidosis IVA treatment. [PDF]
Leal AF, Pachajoa H.
europepmc +1 more source
Clinical and molecular spectrum of mucopolysaccharidosis IVA in Iraqi children: Allele-specific genotype-phenotype trends and novel GALNS variants. [PDF]
Wahhab SBA, Thejeal RF.
europepmc +1 more source
Early screening for respiratory and cardiac complications in pediatric mucopolysaccharidosis IVA: Insights from a case. [PDF]
Shu H +5 more
europepmc +1 more source
Diagnostic and therapeutic applications of the glycan biomarker H3N2b in GM1 Gangliosidosis. [PDF]
Kell P +14 more
europepmc +1 more source
Advances in mucopolysaccharidosis research: the impact of mass spectrometry-based approaches. [PDF]
Ramarajan MG +3 more
europepmc +1 more source
Long-Term Liver-Targeted AAV8 Gene Therapy for Mucopolysaccharidosis IVA. [PDF]
Khan SA +5 more
europepmc +1 more source
C-Type Natriuretic Peptide Derivatives: Orthopaedic Implications in Achondroplasia. [PDF]
Qian E, Chen K, Montoya R, Sabharwal S.
europepmc +1 more source
Mucopolysaccharidoses-What Clinicians Need to Know: A Clinical, Biochemical, and Molecular Overview. [PDF]
Lipiński P +11 more
europepmc +1 more source
Epigenetic landscape in lysosomal storage disorders: mechanisms and modulation. [PDF]
Leal AF, Pachajoa H, Tomatsu S.
europepmc +1 more source

